IDEXX LABORATORIES INC (IDXX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for IDXX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| IDXX | Executive Chair of the Board; President and Chief Executive Officer, IDEXX Laboratories, Inc.; President and CEO | 65 | ["Executive leadership", "Corporate strategy", "Innovation and R&D", "Extensive leadership and management experience gained during his time in various roles at IDEXX", "Deep experience developing and implementing strategies for continued long-term sustainable growth at IDEXX", "Substantial experience leading organizations to create innovative, integrated healthcare solutions", "Significant corporate governance, financial acumen, human capital management, international business, digital, corporate finance, operations, sustainability and risk oversight skills and experience"] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| XRAY | President and CEO | 65 | ["President and CEO of IDEXX Laboratories, Inc.","Executive Vice President responsible for IDEXX’s North American Companion Animal Group Commercial Organization","Senior Vice President and General Manager at Philips Healthcare","Executive in Charge at Agilent Technologies","General Manager at Agilent Technologies","Held roles at Hewlett Packard in finance, marketing and business planning","Undergraduate degree in Mathematics from the University of Rochester","MBA from the University of Chicago","Large Company Experience","DENTSPLY SIRONA History and Industry","Medical Device or Industry Experience","International Business Experience","Financial Literacy","Public Company Governance Experience","Experience in Marketing and Sales","Experience in HR and Talent Management","Large Company Experience as an Executive"] | ["Compensation & Human Capital Committee","Corporate Governance and Nominating Committee","Science and Technology Committee"] | 2026 |
Biography sourced from the proxy statement filing.
President and Chief Executive Officer, IDEXX Laboratories, Inc. Director Age: 65 Director since: October 2019 Committees: None Other current public company director service: + Dentsply Sirona Inc. (since May 2023) Experience IDEXX + President and Chief Executive Officer (since October 2019) + Interim President and Chief Executive Officer (June 2019 October 2019) + Executive Vice President (August 2012 June 2019) Philips Healthcare, a subsidiary of Royal Philips Electronics (now named Royal Philips) + Senior Vice President and General Manager, Computed Tomography, Nuclear Medicine and Radiation Therapy Planning (2010 2012) + Various roles of increasing responsibility (2001 2010) Agilent Technologies (acquired by Royal Philips Electronics in 2001) + Executive in Charge, Agilent Healthcare Solutions Group divestiture (2000 2002) + General Manager, Medical Consumables Business Unit (1997 2000) Hewlett Packard + Various roles in finance, marketing and business planning (1988 1996) Qualifications + Executive Leadership: Extensive leadership and management experience gained during his time in various roles at IDEXX, including as President and Chief Executive Officer, during which time he has prioritized innovation, built expanded commercial capabilities and scaled our warehouse, distribution and manufacturing capabilities to support continued growth, and as Executive Vice President, where he was responsible for the North American Companion Animal Group Commercial Organization and key elements of the innovation portfolio, including IDEXX VetLab In-house Diagnostics, Diagnostic Imaging, Veterinary Software and Services, Rapid Assay and Telemedicine lines of business. + Corporate Strategy: Deep experience developing and implementing strategies for continued long-term sustainable growth at IDEXX, including transforming our go-to-market strategy in North America in 2014, significant international commercial expansions, investments in innovation and an emphasis on delivering a differentiated customer experience. + Innovation and R&D: Substantial experience leading organizations to create innovative, integrated healthcare solutions that improve the standard of care, including at Philips Healthcare and IDEXX; as President and Chief Executive Officer of IDEXX, he has prioritized investment in (and focus on) intelligent innovation, resulting in the introduction of multiple customer-centric products and services that will advance pet healthcare, including IDEXX Cancer Dx (a first-of-its-kind diagnostic panel that detects canine lymphoma), IDEXX inVue Dx Cellular Analyzer (a slide-free instrument that assesses cells in their natural state) and Vello (a pet-owner engagement software solution). + Mr. Mazelsky also brings significant corporate governance, financial acumen, human capital management, international business, digital, corporate finance (including mergers and acquisitions), operations, sustainability and risk oversight skills and experience to the Board. Education + BA, Mathematics, University of Rochester + MBA, University of Chicago Booth School of Business